
|Articles|August 1, 2002
The American Journal of Managed Care
- August 2002
- Volume 8
- Issue 8
The Comparative Clinical and Economic Benefits of Drugs Should be Established and Discussed as Part of any Formulary Decision Process
Advertisement
Articles in this issue
about 23 years ago
A New Era of Leadershipabout 23 years ago
The Potential of Pill Splitting to Achieve Cost Savingsabout 23 years ago
Rational Use of Antibiotics to Treat Respiratory Tract Infectionsabout 23 years ago
Reducing Cesarean Delivery Rates in Managed Care OrganizationsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Boosting RSV Vaccination in Older Adults Could Save Thousands
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5














































